List of countries ineligible for prepaid return labels

While we can still dispatch our kits to the listed countries, we are regrettably unable to generate prepaid return labels for these destinations.

Customers will be required to purchase their own return labels from their preferred courier service at their own expense. Shipping costs have been prorated to account for the absence of a prepaid return label.

List of countries ineligible for prepaid return labels:

  1. Brazil
  2. Bulgaria
  3. Colombia
  4. Côte d’Ivoire
  5. Cyprus
  6. Estonia
  7. Ghana
  8. Greece
  9. Hong Kong
  10. Indonesia
  11. Israel
  12. Japan
  13. Kazakhstan
  14. Kuwait
  15. Luxembourg
  16. Mexico
  17. Monaco
  18. New Zealand
  19. Nigeria
  20. Norway
  21. Portugal
  22. Qatar
  23. Romania
  24. Saudi Arabia
  25. Serbia
  26. Singapore
  27. Slovakia
  28. South Africa
  29. Switzerland
  30. Thailand
  31. United Arab Emirates

Addresses to return your kit to

If you are returning your sample from Mexico, please return your kit to this address:

Clinical Accessioning
1445 N Loop W, Suite 820
Houston, TX 77008

If you are returning your sample from within the European Union (ex: Czechia, Estonia, Luxembourg, etc.), please return your kit to this address:

Eurofins Genomics A/S
Attn: Caecilie Martina Mink
Brendstrupgaardsvej 23
8200 Aarhus N
Denmark
(tel. +45 26864360)

If you are returning your sample from outside the European Union (ex: NZ, South Africa, UAE etc.), please return your kit to this address:

Eurofins Genomics Europe,
Jenan Alhasabi
Units 2 & 3, Java Park
Bradbourne Drive, Tilbrook
Milton Keynes MK7 8AT
UK
(tel. +44 07552584125)

Please choose the "tracked" option so you can monitor your kit's progress back to us.

We do not accept "cash on delivery" (COD) deliveries. COD deliveries will be rejected and returned to you by the courier.

This list is subject to change. Please refer back to this article or email us at support@selfdecode.com for the most up-to-date list.

Did this answer your question? Thanks for the feedback There was a problem submitting your feedback. Please try again later.